Swixx Biopharma acquires Biopas to enter Latin America

Cuatrecasas has contributed to advising Swixx Biopharma AG, a global commercial platform dedicated to unlocking access to innovative medicines worldwide, on acquiring Pharma Consulting Group S.A. and its subsidiary Laboratorios Biopas S.A. (Biopas), as part of its strategic expansion into Latin America. 

Biopas is a leading pharmaceutical company in Latin America, specializing in the in-licensing, marketing, and sale of pharmaceutical products. With operational headquarters in Bogota (Colombia), Biopas is one of Latin America’s leading independent marketing and distribution companies for international biopharmaceutical firms. Biopas has a presence in 20 countries, including Latin America’s “Top 5” markets of Argentina, Brazil, Chile, Colombia, and Mexico. Following this transaction, the leadership team will remain at the helm of the combined company in Latin America.

Walder Wyss acted as lead legal advisor for Swixx Biopharma AG and was supported by the law firms Cuatrecasas, Arias Fábrega & Fábrega (ARIFA) and Pérez Alati, Grondona, Benites & Arntsen (PAGBAM) in Latin America. 

The Cuatrecasas team was led by partner Kai Christian Fischer and counsel Javier Alós, both from Corporate/M&A, and included lawyers from Spain (Ana Laso and Laura Ramírez), Colombia (Juan Felipe Vera, Sebastián Salazar, Carolina Trejos, Rafael Marulanda, Juan Sebastian Bustillo, Daniel Albornoz, Alejandro Cepeda, José Manuel Jaramillo, Juan Camilo Rangel and María Alejandra Rueda), Mexico (Iván Libenson, Jorge Enrique García De Presno, Sebastián García and Jerónimo Rico) and Peru (Óscar Trelles and Augusto Tomás Hostia).